v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Pre-Funded Warrants
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Pre-Funded Warrants
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024     32,995,822        
Beginning balance at Dec. 31, 2024 $ 322,280   $ 3 $ 2,794,871   $ (2,472,872) $ 278
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (84,487)         (84,487)  
Other comprehensive income (loss) (180)           (180)
Stock-based compensation for equity-classified awards 4,833     4,833      
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     49,040        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (50)     (50)      
Issuance of common stock pursuant to at-the-market offering (in shares)     6,946,164        
Issuance of common stock pursuant to at-the-market offering 30,730   $ 1 30,729      
Transaction costs (955)     (955)      
Ending balance (in shares) at Mar. 31, 2025     39,991,026        
Ending balance at Mar. 31, 2025 272,171   $ 4 2,829,428   (2,557,359) 98
Beginning balance (in shares) at Dec. 31, 2024     32,995,822        
Beginning balance at Dec. 31, 2024 322,280   $ 3 2,794,871   (2,472,872) 278
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (151,767)            
Ending balance (in shares) at Jun. 30, 2025     55,786,653        
Ending balance at Jun. 30, 2025 263,373   $ 6 2,888,020   (2,624,639) (14)
Beginning balance (in shares) at Mar. 31, 2025     39,991,026        
Beginning balance at Mar. 31, 2025 272,171   $ 4 2,829,428   (2,557,359) 98
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (67,280)         (67,280)  
Other comprehensive income (loss) (112)           (112)
Stock-based compensation for equity-classified awards 4,741     4,741      
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     69,473        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (55)     (55)      
Issuance of common stock pursuant to at-the-market offering (in shares)     15,726,154        
Issuance of common stock pursuant to at-the-market offering 55,600   $ 2 55,598      
Transaction costs (1,692)     (1,692)      
Ending balance (in shares) at Jun. 30, 2025     55,786,653        
Ending balance at Jun. 30, 2025 $ 263,373   $ 6 2,888,020   (2,624,639) (14)
Beginning balance (in shares) at Dec. 31, 2025 73,326,504   73,326,504        
Beginning balance at Dec. 31, 2025 $ 273,964   $ 7 3,025,604   (2,751,779) 132
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (64,715)         (64,715)  
Other comprehensive income (loss) (88)           (88)
Stock-based compensation for equity-classified awards 3,928     3,928      
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     6,140        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (8)     (8)      
Issuance of common stock pursuant to at-the-market offering (in shares)     3,970,640        
Issuance of common stock pursuant to at-the-market offering 10,961     10,961      
Exercises of Pre-Funded Warrants (in shares)     4,106,056        
Exercises of Pre-Funded Warrants 1   $ 1        
Transaction costs (314)     (314)      
Ending balance (in shares) at Mar. 31, 2026     81,409,340        
Ending balance at Mar. 31, 2026 $ 223,729   $ 8 3,040,171   (2,816,494) 44
Beginning balance (in shares) at Dec. 31, 2025 73,326,504   73,326,504        
Beginning balance at Dec. 31, 2025 $ 273,964   $ 7 3,025,604   (2,751,779) 132
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (120,604)            
Ending balance (in shares) at Jun. 30, 2026 141,277,897   141,277,897        
Ending balance at Jun. 30, 2026 $ 396,114   $ 14 3,268,427   (2,872,383) 56
Beginning balance (in shares) at Mar. 31, 2026     81,409,340        
Beginning balance at Mar. 31, 2026 223,729   $ 8 3,040,171   (2,816,494) 44
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (55,889)         (55,889)  
Other comprehensive income (loss) 12           12
Stock-based compensation for equity-classified awards 6,861     6,861      
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)     1,118,850        
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (1,785)     (1,785)      
Issuance of common stock pursuant to at-the-market offering (in shares)     41,013,382        
Issuance of common stock pursuant to at-the-market offering 134,059   $ 4 134,055      
Issuance of common stock pursuant to the redemption and exchange of debt (in shares)     17,542,577        
Issuance of common stock pursuant to the redemption and exchange of debt 61,931   $ 2 61,929      
Issuance of pre-funded warrants pursuant to exchange of debt   $ 30,315     $ 30,315    
Issuance of common stock related to the employee stock purchase plan (in shares)     193,748        
Issuance of common stock related to the employee stock purchase plan 476     476      
Transaction costs $ (3,595)     (3,595)      
Ending balance (in shares) at Jun. 30, 2026 141,277,897   141,277,897        
Ending balance at Jun. 30, 2026 $ 396,114   $ 14 $ 3,268,427   $ (2,872,383) $ 56